The Scottish Medicines Consortium (SMC) has issued advice on six different medicines, advising healthcare professionals as to whether they have been accepted for use, accepted for restricted use, or not recommended for use in NHS Scotland.
The medicines are listed under the following British National Formulary categories:
- Drugs used in diabetes
- insulin aspart—accepted for use.
- Antiviral drugs
- emtricitabine/tenofovir disoproxil fumarate—accepted for use.
Malignant disease and immunosuppression
- Cytotoxic drugs
- Drugs affecting the immune response
- daclizumab—accepted for restricted use.
- Preparations for eczema and psoriasis
- ixekizumab—accepted for restricted use.
The SMC aims to ensure that newly licensed medications representing good value for money are accepted for routine use in NHS Scotland as quickly as possible. It does this by bringing together a consortium that is made up of lead clinicians, pharmacists, and health economists, as well as representatives from health boards, the pharmaceutical industry, and the public.